Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000204543 | SCV000261553 | benign | Colorectal cancer, susceptibility to, 10 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000204543 | SCV000489308 | likely benign | Colorectal cancer, susceptibility to, 10 | 2016-09-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000679473 | SCV000521703 | likely benign | not provided | 2021-10-11 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28577310, 28423643) |
Prevention |
RCV000679473 | SCV000806458 | likely benign | not provided | 2016-12-30 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000679473 | SCV000888430 | benign | not provided | 2022-09-03 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000204543 | SCV001141140 | likely benign | Colorectal cancer, susceptibility to, 10 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000437496 | SCV001370705 | benign | not specified | 2020-05-07 | criteria provided, single submitter | clinical testing | Variant summary: POLD1 c.1138-8A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 3/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00061 in 251010 control chromosomes, predominantly at a frequency of 0.0016 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 113 fold of the estimated maximal expected allele frequency for a pathogenic variant in POLD1 causing Colorectal Cancer phenotype (1.4e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. To our knowledge, no experimental evidence demonstrating its impact on protein function have been reported. Eight ClinVar submitters (evaluation after 2014) cite the variant as benign (2x) and likely benign (6x). Based on the evidence outlined above, the variant was classified as benign. |
Sema4, |
RCV000664280 | SCV002529047 | benign | Hereditary cancer-predisposing syndrome | 2020-11-16 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000437496 | SCV002551904 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000679473 | SCV003918170 | benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | POLD1: BS1, BS2 |
KCCC/NGS Laboratory, |
RCV000204543 | SCV004016635 | benign | Colorectal cancer, susceptibility to, 10 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000204543 | SCV004018511 | likely benign | Colorectal cancer, susceptibility to, 10 | 2023-04-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Diagnostic Laboratory, |
RCV000204543 | SCV000733913 | likely benign | Colorectal cancer, susceptibility to, 10 | no assertion criteria provided | clinical testing | ||
True Health Diagnostics | RCV000664280 | SCV000788124 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-24 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000679473 | SCV001808528 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000679473 | SCV001919141 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000679473 | SCV001951919 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000679473 | SCV001971753 | likely benign | not provided | no assertion criteria provided | clinical testing |